Cargando…

Systematic study of cilostazol on secondary stroke prevention: a meta-analysis

BACKGROUND: To study the efficacy and safety of cilostazol on ischemic stroke prevention and treatment, systematic reviews of related clinical randomized controlled trials were analyzed. METHODS: We searched the main databases for eligible trials including literature from January 1966 to November 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yining, Bi, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029517/ https://www.ncbi.nlm.nih.gov/pubmed/24313983 http://dx.doi.org/10.1186/2047-783X-18-53

Ejemplares similares

Retraction Note: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2015)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Tan, Choon Han, et al.
Publicado: (2021)

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
por: McHutchison, Caroline, et al.
Publicado: (2020)

The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis
por: Chai, Erqing, et al.
Publicado: (2022)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
por: Galyfos, George, et al.
Publicado: (2017)

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
por: Shi, LiGen, et al.
Publicado: (2014)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023)

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
por: Lee, Su-Yun, et al.
Publicado: (2008)

Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation
por: Kawanabe, Yoshifumi, et al.
Publicado: (2012)

Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis
por: Liang, Xinyu, et al.
Publicado: (2022)

Effects of clazosentan, cilostazol, and statins on aneurysmal subarachnoid hemorrhage: A protocol for systematic review and meta-analysis
por: He, Junfang, et al.
Publicado: (2020)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
por: Park, Joon Beom, et al.
Publicado: (2023)

Multimodal Secondary Prevention Behavioral Interventions for TIA and Stroke: A Systematic Review and Meta-Analysis
por: Lawrence, Maggie, et al.
Publicado: (2015)

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
por: Heo, Sung Hyuk, et al.
Publicado: (2012)

Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model
por: Tara, Shuhei, et al.
Publicado: (2015)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
por: Lee, Tsong-Hai, et al.
Publicado: (2020)

Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial
por: Lim, Jae-Sung, et al.
Publicado: (2021)

The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis
por: Qian, Cong, et al.
Publicado: (2015)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS
por: Bhatt, Nejal M., et al.
Publicado: (2015)

Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study
por: Ohnuki, Yoichi, et al.
Publicado: (2017)

Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis
por: Toyoda, Kazunori, et al.
Publicado: (2022)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke
por: Zhang, Wen-hui, et al.
Publicado: (2015)

The Role of Pharmacists in Providing Pharmaceutical Care in Primary and Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis
por: Al-Qahtani, Saeed, et al.
Publicado: (2022)

Efficacy of Cilostazol on Uncontrolled Coronary Vasospastic Angina: A Pilot Study
por: Yoo, Sang-Yong, et al.
Publicado: (2013)

Systematic Development of Structured Semi-interactive Stroke Prevention Package for Secondary Stroke Prevention
por: Kate, Mahesh Pundlik, et al.
Publicado: (2020)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Effects of cilostazol on the heart rate in healthy dogs
por: FUKUSHIMA, Ryuji, et al.
Publicado: (2018)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset
por: Aoki, Junya, et al.
Publicado: (2019)

Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study
por: Senda, Joe, et al.
Publicado: (2019)

Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Tramacere, Irene, et al.
Publicado: (2019)

Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Del Giovane, Cinzia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hu8h17fd12kfra8agui0tc8jc